Sequence information
Variant position: 51 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: 226 The length of the canonical sequence.
Location on the sequence:
LGLGARTYSQGDCSYSRTAL
Y DLLGVPSTATQAQIKAAYYR
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human LGLGARTYSQGDCSYSRTALY DLLGVPSTATQAQIKAAYYR
Mouse LCSRGRTYS-------RTALY ELLGVPSTATQAQIKAAYYR
Sequence annotation in neighborhood: The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Type Positions Description
Chain
39 – 226
DnaJ homolog subfamily C member 30, mitochondrial
Domain
49 – 114
J
Helix
49 – 54
Literature citations
Impaired complex I repair causes recessive Leber's hereditary optic neuropathy.
Stenton S.L.; Sheremet N.L.; Catarino C.B.; Andreeva N.A.; Assouline Z.; Barboni P.; Barel O.; Berutti R.; Bychkov I.; Caporali L.; Capristo M.; Carbonelli M.; Cascavilla M.L.; Charbel Issa P.; Freisinger P.; Gerber S.; Ghezzi D.; Graf E.; Heidler J.; Hempel M.; Heon E.; Itkis Y.S.; Javasky E.; Kaplan J.; Kopajtich R.; Kornblum C.; Kovacs-Nagy R.; Krylova T.D.; Kunz W.S.; La Morgia C.; Lamperti C.; Ludwig C.; Malacarne P.F.; Maresca A.; Mayr J.A.; Meisterknecht J.; Nevinitsyna T.A.; Palombo F.; Pode-Shakked B.; Shmelkova M.S.; Strom T.M.; Tagliavini F.; Tzadok M.; van der Ven A.T.; Vignal-Clermont C.; Wagner M.; Zakharova E.Y.; Zhorzholadze N.V.; Rozet J.M.; Carelli V.; Tsygankova P.G.; Klopstock T.; Wittig I.; Prokisch H.;
J. Clin. Invest. 131:0-0(2021)
Cited for: VARIANTS LHONAR CYS-51; SER-78 AND GLN-101; INVOLVEMENT IN LHONAR; CHARACTERIZATION OF VARIANTS LHONAR CYS-51; SER-78 AND GLN-101; FUNCTION;
Disclaimer:
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.